Management of Hepatitis C Infection with Direct Action Antiviral Drugs (DAA)**

• Egile Nagusiak: Roberto Focaccia (Egilea), Rodolfo Ferreira de Mello (Egilea), Patrícia Silva Montes (Egilea), Flávio Martin Conti (Egilea)
• Formatua: Liburua
• Argitaratua: Archives of Hepatitis Research - Peertechz Publications, 2015-12-30.
• Gaiak: Review Article
• Sarrera elektronikoa: Connect to this object online.

<p>Several new direct action antiviral drugs (DAA) against the HCV virus (HCV) are approved and marketed. The combination of DAA with pegylated interferon and ribavirin (PR) is only recommended to patients with tolerance to interferon (IFN). IFN-free treatments are now considered elective drug...